Congress reached a bipartisan deal on health care that funds the National Institutes of Health (NIH) at $48.7 billion, an increase of $415 million over 2025[1]. The agreement includes measures to regulate pharmaceutical intermediaries known as pharmacy benefit managers (PBMs), which are considered a problem in the healthcare industry[4]. The package also extends the telemedicine care and hospital-level care program to the home until the end of 2027[4]. Congress increased funding to community health centers to $4.6 billion and approved Medicare coverage of screening tests for several types of cancer[4]. The agreement also contains language safeguards to prevent the Trump administration from reducing support for research overheads[1]. While the package includes funding increases for the NIH and other health programs, it does not restore increased subsidies to the Affordable Care Act, which expire at the end of 2024[4]. The legislation has yet to pass a vote in the House of Representatives and the Senate and be signed by the president[1].